• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effect of nepafenac 0.1% on retinal thickness after cataract surgery in patients without risk factors for cystoid macular edema.0.1%奈帕芬胺对无黄斑囊样水肿危险因素患者白内障手术后视网膜厚度的影响。
Int J Ophthalmol. 2020 Dec 18;13(12):1901-1907. doi: 10.18240/ijo.2020.12.09. eCollection 2020.
2
Incidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenac.接受奈帕芬酸治疗的患者在白内障超声乳化术后发生具有视觉意义的人工晶状体性黄斑水肿的发生率。
J Cataract Refract Surg. 2007 Sep;33(9):1546-9. doi: 10.1016/j.jcrs.2007.05.018.
3
Impact of nepafenac 0.1% on macular thickness and postoperative visual acuity after cataract surgery in patients at low risk for cystoid macular oedema.在低风险白内障患者中,使用奈帕芬胺 0.1% 对术后黄斑厚度和视力的影响。
Eye (Lond). 2010 Jan;24(1):90-6. doi: 10.1038/eye.2009.10. Epub 2009 Feb 20.
4
Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial.地塞米松、奈帕芬胺和溴芬酸预防人工晶状体性黄斑囊样水肿疗效的比较:一项开放标签、前瞻性、随机对照试验。
Curr Eye Res. 2018 Mar;43(3):362-367. doi: 10.1080/02713683.2017.1396615. Epub 2017 Nov 9.
5
Intraindividual comparison of nepafenac 0.3% for the prevention of macular edema after phacoemulsification.白内障超声乳化术后应用奈帕芬胺 0.3%预防黄斑水肿的个体内比较。
J Cataract Refract Surg. 2018 Apr;44(4):440-446. doi: 10.1016/j.jcrs.2018.01.026. Epub 2018 Apr 22.
6
Functional and anatomical evaluation of the effect of nepafenac in prevention of macular edema after phacoemulsification in diabetic patients.奈帕芬胺预防糖尿病患者白内障超声乳化术后黄斑水肿效果的功能及解剖学评估
Int J Ophthalmol. 2019 Mar 18;12(3):387-392. doi: 10.18240/ijo.2019.03.06. eCollection 2019.
7
Topical nonsteroidal anti-inflammatory drugs as adjuvant therapy in the prevention of macular edema after cataract surgery.局部用非甾体抗炎药作为白内障手术后黄斑水肿预防的辅助治疗。
Int Ophthalmol. 2017 Oct;37(5):1127-1131. doi: 10.1007/s10792-016-0374-5. Epub 2016 Oct 20.
8
Impact of topical nonsteroidal anti-inflammatory drugs in prevention of macular edema following cataract surgery in diabetic patients.局部非甾体类抗炎药对糖尿病患者白内障手术后黄斑水肿预防的影响。
Int J Ophthalmol. 2018 Apr 18;11(4):616-622. doi: 10.18240/ijo.2018.04.13. eCollection 2018.
9
Preoperative anti-inflammatory treatment of diabetic patients does not improve recovery from cataract surgery when postoperatively treated with a combination of prednisolone acetate and nepafenac.术前对糖尿病患者进行抗炎治疗,术后联合使用醋酸泼尼松龙和奈帕芬胺治疗,并不会改善白内障手术的恢复情况。
Acta Ophthalmol. 2019 Sep;97(6):589-595. doi: 10.1111/aos.14018. Epub 2019 Jan 8.
10
Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo.人工晶状体眼黄斑囊样水肿的预防及危险因素;0.3%奈帕芬胺滴眼液每日一次辅助治疗与安慰剂对照的前瞻性研究
BMC Ophthalmol. 2017 Feb 20;17(1):16. doi: 10.1186/s12886-017-0405-7.

本文引用的文献

1
Intraindividual comparison of nepafenac 0.3% for the prevention of macular edema after phacoemulsification.白内障超声乳化术后应用奈帕芬胺 0.3%预防黄斑水肿的个体内比较。
J Cataract Refract Surg. 2018 Apr;44(4):440-446. doi: 10.1016/j.jcrs.2018.01.026. Epub 2018 Apr 22.
2
Impact of topical nonsteroidal anti-inflammatory drugs in prevention of macular edema following cataract surgery in diabetic patients.局部非甾体类抗炎药对糖尿病患者白内障手术后黄斑水肿预防的影响。
Int J Ophthalmol. 2018 Apr 18;11(4):616-622. doi: 10.18240/ijo.2018.04.13. eCollection 2018.
3
Preexisting epiretinal membrane is associated with pseudophakic cystoid macular edema.既往存在的视网膜前膜与人工晶状体眼黄斑囊样水肿相关。
Graefes Arch Clin Exp Ophthalmol. 2018 May;256(5):909-917. doi: 10.1007/s00417-018-3954-4. Epub 2018 Mar 21.
4
Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial.地塞米松、奈帕芬胺和溴芬酸预防人工晶状体性黄斑囊样水肿疗效的比较:一项开放标签、前瞻性、随机对照试验。
Curr Eye Res. 2018 Mar;43(3):362-367. doi: 10.1080/02713683.2017.1396615. Epub 2017 Nov 9.
5
Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy: Results of 2 Randomized Phase 3 Studies.白内障手术后糖尿病视网膜病变患者应用 0.3% 奈帕芬胺:两项随机 3 期研究结果。
Ophthalmology. 2017 Jun;124(6):776-785. doi: 10.1016/j.ophtha.2017.01.036. Epub 2017 Mar 6.
6
Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo.人工晶状体眼黄斑囊样水肿的预防及危险因素;0.3%奈帕芬胺滴眼液每日一次辅助治疗与安慰剂对照的前瞻性研究
BMC Ophthalmol. 2017 Feb 20;17(1):16. doi: 10.1186/s12886-017-0405-7.
7
The comparative efficacy and safety of topical non-steroidal anti-inflammatory drugs for the treatment of anterior chamber inflammation after cataract surgery: a systematic review and network meta-analysis.局部用非甾体抗炎药治疗白内障术后前房炎症的比较疗效与安全性:一项系统评价和网状Meta分析
Graefes Arch Clin Exp Ophthalmol. 2017 Apr;255(4):639-649. doi: 10.1007/s00417-017-3599-8. Epub 2017 Jan 27.
8
Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery.预防性使用非甾体抗炎药预防白内障手术后黄斑水肿。
Cochrane Database Syst Rev. 2016 Nov 1;11(11):CD006683. doi: 10.1002/14651858.CD006683.pub3.
9
Dexamethasone 0.7 mg implants in the management of pseudophakic cystoid macular edema.0.7毫克地塞米松植入物用于治疗人工晶状体眼黄斑囊样水肿
Arq Bras Oftalmol. 2016 Apr;79(2):113-5. doi: 10.5935/0004-2749.20160033.
10
Prostaglandin E Levels of Aqueous and Vitreous Humor in Ketorolac 0.4% and Nepafenac 0.1% Administered Healthy Rabbits.在给予0.4%酮咯酸和0.1%奈帕芬胺的健康兔眼中房水和玻璃体液的前列腺素E水平
Ocul Immunol Inflamm. 2017 Jun;25(3):323-327. doi: 10.3109/09273948.2015.1116587. Epub 2016 Jan 14.

0.1%奈帕芬胺对无黄斑囊样水肿危险因素患者白内障手术后视网膜厚度的影响。

Effect of nepafenac 0.1% on retinal thickness after cataract surgery in patients without risk factors for cystoid macular edema.

作者信息

Şahin Asena Keleş, Kükner Ahmet Şahap, Ulaş Fatih, Doğan Ümit

机构信息

Department of Ophthalmology, Training and Research Hospital, Ordu University, Ordu 52000, Turkey.

Department of Ophthalmology, Faculty of Medicine, Bolu Abant Izzet Baysal University, Bolu 14280, Turkey.

出版信息

Int J Ophthalmol. 2020 Dec 18;13(12):1901-1907. doi: 10.18240/ijo.2020.12.09. eCollection 2020.

DOI:10.18240/ijo.2020.12.09
PMID:33344188
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7708356/
Abstract

AIM

To evaluate the effect of topical preoperative nepafenac 0.1% treatment on postoperative macular edema using optical coherence tomography (OCT) after uncomplicated cataract surgery.

METHODS

Ninety eyes of 90 patients without any risk factors were included in the study. The patients were assigned to three groups: group 1, treated with topical prednisolone acetate 1%; group 2, treated with topical nepafenac 0.1% in addition to prednisolone acetate (1%); and group 3, those who started receiving nepafenac 0.1% treatment 3d prior to surgery and continued the treatment postoperatively in addition to prednisolone acetate (1%). Central retinal thickness (CRT) and macular volume values were recorded using OCT at weeks 3 and 6.

RESULTS

The increases in macular volume in the central 1 mm area after 3 and 6wk were significantly lower in patients who used prophylactic topical nepafenac preoperatively (group 3) compared with those in group 1 (=0.028 and 0.008, respectively). No significant differences in the increase in macular volume and CRT were noted between groups 2 and 3 (>0.05). In group 1, the increases in macular volume in the central 3 mm area at weeks 3 and 6 were significantly higher than that in group 2 and 3 (3 week, =0.004; 6 week, =0.005).

CONCLUSION

Nepafenac 0.1% treatment in addition to topical steroids after uncomplicated cataract surgery reduce the increase in macular volume in the early postoperative period.

摘要

目的

使用光学相干断层扫描(OCT)评估术前局部应用0.1%奈帕芬酸治疗对单纯性白内障手术后黄斑水肿的影响。

方法

本研究纳入了90例无任何危险因素患者的90只眼。患者被分为三组:第1组,局部应用1%醋酸泼尼松龙治疗;第2组,除1%醋酸泼尼松龙外,局部应用0.1%奈帕芬酸治疗;第3组,在手术前3天开始接受0.1%奈帕芬酸治疗,并在术后继续治疗,同时联合1%醋酸泼尼松龙。在第3周和第6周时使用OCT记录中心视网膜厚度(CRT)和黄斑体积值。

结果

术前预防性局部应用奈帕芬酸的患者(第3组)在术后3周和6周时,中心1mm区域黄斑体积的增加显著低于第1组患者(分别为=0.028和0.008)。第2组和第3组之间黄斑体积增加和CRT方面无显著差异(>0.05)。在第1组中,第3周和第6周时中心3mm区域黄斑体积的增加显著高于第2组和第3组(第3周,=0.004;第6周,=0.005)。

结论

单纯性白内障手术后,除局部应用类固醇外,应用0.1%奈帕芬酸治疗可减少术后早期黄斑体积的增加。